Cargando…
Lansoprazole-Induced Improvement of Esophageal Submucosal Injury
The proton pumpvinhibitor, lansoprazole, is reported to have acid secretion inhibiting effect as well as anti-inflammatory effects such as inhibition of cytokine secretion from inflammatory cells. Clinically, excellent efficacy of lansoprazole is reported for not only gastric ulcer but also gastroes...
Autores principales: | Mine, Shinichiro, Tanaka, Yoshiya |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
the Society for Free Radical Research Japan
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2170952/ https://www.ncbi.nlm.nih.gov/pubmed/18193102 http://dx.doi.org/10.3164/jcbn.2007013 |
Ejemplares similares
-
The Expression of Heme Oxygenase-1 Induced by Lansoprazole
por: Takagi, Tomohisa, et al.
Publicado: (2009) -
Prevention of NSAID-Induced Small Intestinal Mucosal Injury: Prophylactic Potential of Lansoprazole
por: Higuchi, Kazuhide, et al.
Publicado: (2009) -
Immune and Inflammatory Responses in GERD and Lansoprazole
por: Isomoto, Hajime, et al.
Publicado: (2007) -
Lansoprazole Novel Effector Sites Revealed by Autoradiography: Relation to Helicobacter pylori, Colon, Esophagus and Others
por: Nakamura, Masahiko, et al.
Publicado: (2007) -
Endoscopic Submucosal Dissection in the Era of Proton Pump Inhibitors
por: Isomoto, Hajime, et al.
Publicado: (2009)